How Do I Streamline Early Drug Development While Planning For The Future?

Because of the industry-wide needs for R&D efficacy, there has been an increasing emphasis on speed and cost savings to get into clinic quickly.  This may lead to a gap in the focus on chemistry, manufacturing and chemistry controls (CMC) between early- and late- phase development.  Companies should create a development strategy that bridges such potential gaps earlier in the process to make the transition smoother.

Download the Article